Ajanta Pharma Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AJANTA PHARMA LTD, and what generic and branded alternatives to AJANTA PHARMA LTD drugs are available?
AJANTA PHARMA LTD has sixty-three approved drugs.
There are three tentative approvals on AJANTA PHARMA LTD drugs.
Summary for Ajanta Pharma Ltd
US Patents: | 0 |
Tradenames: | 53 |
Ingredients: | 52 |
NDAs: | 63 |
Drug Master File Entries: | 2 |
Drugs and US Patents for Ajanta Pharma Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ajanta Pharma Ltd | TOPIRAMATE | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 215663-003 | Aug 15, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Ajanta Pharma Ltd | RANITIDINE HYDROCHLORIDE | ranitidine hydrochloride | CAPSULE;ORAL | 209859-002 | Sep 27, 2018 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Ajanta Pharma Ltd | SOLIFENACIN SUCCINATE | solifenacin succinate | TABLET;ORAL | 205483-001 | May 20, 2019 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.